HK1073243A1 - Use of N-(indolecarbonyl-) piperazine derivatives - Google Patents
Use of N-(indolecarbonyl-) piperazine derivativesInfo
- Publication number
- HK1073243A1 HK1073243A1 HK05105839A HK05105839A HK1073243A1 HK 1073243 A1 HK1073243 A1 HK 1073243A1 HK 05105839 A HK05105839 A HK 05105839A HK 05105839 A HK05105839 A HK 05105839A HK 1073243 A1 HK1073243 A1 HK 1073243A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- indolecarbonyl
- piperazine derivatives
- piperazine
- derivatives
- Prior art date
Links
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10157673A DE10157673A1 (de) | 2001-11-24 | 2001-11-24 | Verwendung von N-(Indolcarbonyl-)piperazinderivaten |
| PCT/EP2002/012009 WO2003045392A2 (de) | 2001-11-24 | 2002-10-28 | Verwendung von n-(indolcarbonyl-)piperazinderivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1073243A1 true HK1073243A1 (en) | 2005-09-30 |
Family
ID=7706831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05105839A HK1073243A1 (en) | 2001-11-24 | 2005-07-11 | Use of N-(indolecarbonyl-) piperazine derivatives |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20050014766A1 (zh) |
| EP (1) | EP1448201B1 (zh) |
| JP (1) | JP2005511640A (zh) |
| KR (1) | KR100953172B1 (zh) |
| CN (1) | CN1319532C (zh) |
| AR (1) | AR037404A1 (zh) |
| AU (1) | AU2002349012B2 (zh) |
| BR (1) | BR0214347A (zh) |
| CA (1) | CA2468380A1 (zh) |
| DE (2) | DE10157673A1 (zh) |
| ES (1) | ES2297018T3 (zh) |
| HK (1) | HK1073243A1 (zh) |
| HU (1) | HUP0402388A3 (zh) |
| IL (2) | IL162125A0 (zh) |
| MX (1) | MXPA04004766A (zh) |
| MY (1) | MY141210A (zh) |
| NZ (1) | NZ533667A (zh) |
| PE (1) | PE20030710A1 (zh) |
| PL (1) | PL207565B1 (zh) |
| RU (1) | RU2317083C2 (zh) |
| UA (1) | UA77468C2 (zh) |
| WO (1) | WO2003045392A2 (zh) |
| ZA (1) | ZA200404967B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10246357A1 (de) * | 2002-10-04 | 2004-04-15 | Merck Patent Gmbh | Verwendung von 5-HT2Rezeptorantagonisten |
| DE102004047517A1 (de) * | 2004-09-28 | 2006-03-30 | Merck Patent Gmbh | Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3582371D1 (de) * | 1984-07-06 | 1991-05-08 | Otsuka Pharma Co Ltd | Oxindolverbindungen, diese enthaltende zusammensetzungen sowie verfahren zur herstellung derselben. |
| GB9718712D0 (en) * | 1997-09-03 | 1997-11-12 | Merck Sharp & Dohme | Theraputic Agents |
| EP1076644B1 (en) * | 1998-04-29 | 2004-06-23 | Ortho-McNeil Pharmaceutical, Inc. | N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| GB9825413D0 (en) * | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
| DE19934433A1 (de) * | 1999-07-22 | 2001-01-25 | Merck Patent Gmbh | N-(Indolcarbonyl-)piperazinderivate |
| DE19934432A1 (de) * | 1999-07-22 | 2001-02-01 | Merck Patent Gmbh | Indolderivate |
| US6372743B1 (en) * | 1999-09-30 | 2002-04-16 | Neurogen Corporation | Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines |
-
2001
- 2001-11-24 DE DE10157673A patent/DE10157673A1/de not_active Withdrawn
-
2002
- 2002-10-28 PL PL369675A patent/PL207565B1/pl not_active IP Right Cessation
- 2002-10-28 NZ NZ533667A patent/NZ533667A/en not_active IP Right Cessation
- 2002-10-28 HU HU0402388A patent/HUP0402388A3/hu unknown
- 2002-10-28 EP EP02781293A patent/EP1448201B1/de not_active Expired - Lifetime
- 2002-10-28 DE DE50211298T patent/DE50211298D1/de not_active Expired - Lifetime
- 2002-10-28 UA UA20040604937A patent/UA77468C2/uk unknown
- 2002-10-28 KR KR1020047006419A patent/KR100953172B1/ko not_active IP Right Cessation
- 2002-10-28 WO PCT/EP2002/012009 patent/WO2003045392A2/de active IP Right Grant
- 2002-10-28 US US10/496,572 patent/US20050014766A1/en not_active Abandoned
- 2002-10-28 JP JP2003546894A patent/JP2005511640A/ja active Pending
- 2002-10-28 IL IL16212502A patent/IL162125A0/xx unknown
- 2002-10-28 MX MXPA04004766A patent/MXPA04004766A/es active IP Right Grant
- 2002-10-28 AU AU2002349012A patent/AU2002349012B2/en not_active Ceased
- 2002-10-28 CN CNB028230620A patent/CN1319532C/zh not_active Expired - Fee Related
- 2002-10-28 CA CA002468380A patent/CA2468380A1/en not_active Abandoned
- 2002-10-28 BR BR0214347-0A patent/BR0214347A/pt not_active IP Right Cessation
- 2002-10-28 ES ES02781293T patent/ES2297018T3/es not_active Expired - Lifetime
- 2002-10-28 RU RU2004119303/15A patent/RU2317083C2/ru not_active IP Right Cessation
- 2002-11-20 MY MYPI20024337A patent/MY141210A/en unknown
- 2002-11-20 PE PE2002001114A patent/PE20030710A1/es not_active Application Discontinuation
- 2002-11-22 AR ARP020104495A patent/AR037404A1/es unknown
-
2004
- 2004-05-23 IL IL162125A patent/IL162125A/en not_active IP Right Cessation
- 2004-06-23 ZA ZA200404967A patent/ZA200404967B/en unknown
-
2005
- 2005-07-11 HK HK05105839A patent/HK1073243A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04004766A (es) | 2004-07-30 |
| AU2002349012A1 (en) | 2003-06-10 |
| KR100953172B1 (ko) | 2010-04-20 |
| BR0214347A (pt) | 2004-10-26 |
| IL162125A (en) | 2010-12-30 |
| WO2003045392A8 (de) | 2004-12-29 |
| AU2002349012B2 (en) | 2008-01-24 |
| MY141210A (en) | 2010-03-31 |
| DE50211298D1 (de) | 2008-01-10 |
| RU2004119303A (ru) | 2005-04-20 |
| CA2468380A1 (en) | 2003-06-05 |
| US20050014766A1 (en) | 2005-01-20 |
| AR037404A1 (es) | 2004-11-10 |
| EP1448201A2 (de) | 2004-08-25 |
| HUP0402388A2 (hu) | 2005-03-29 |
| CN1589147A (zh) | 2005-03-02 |
| PE20030710A1 (es) | 2003-08-21 |
| KR20040072624A (ko) | 2004-08-18 |
| JP2005511640A (ja) | 2005-04-28 |
| IL162125A0 (en) | 2005-11-20 |
| ES2297018T3 (es) | 2008-05-01 |
| HUP0402388A3 (en) | 2009-08-28 |
| CN1319532C (zh) | 2007-06-06 |
| DE10157673A1 (de) | 2003-06-05 |
| EP1448201B1 (de) | 2007-11-28 |
| WO2003045392A3 (de) | 2003-09-18 |
| NZ533667A (en) | 2006-11-30 |
| WO2003045392A2 (de) | 2003-06-05 |
| RU2317083C2 (ru) | 2008-02-20 |
| PL207565B1 (pl) | 2011-01-31 |
| ZA200404967B (en) | 2005-08-05 |
| PL369675A1 (en) | 2005-05-02 |
| UA77468C2 (en) | 2006-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1208446A1 (zh) | 的衍生物 | |
| IL157659A0 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| IL156737A0 (en) | Substituted amine derivatives and methods of use | |
| HK1068874A1 (en) | Heterocyclic compounds and methods of use | |
| DK1198453T5 (da) | N-(indolcarbonyl-)piperazinderivater | |
| GB0013378D0 (en) | Use of therapeutic benzamide derivatives | |
| GB0013383D0 (en) | Therapeutic benzamide derivatives | |
| GB0106177D0 (en) | Piperazine derivatives | |
| HK1069385A1 (en) | Heterocyclic compound and medicinal use thereof | |
| GB0013346D0 (en) | Therapeutic benzamide derivatives | |
| PL367676A1 (en) | Novel heterocyclic derivatives and medicinal use thereof | |
| HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
| HUP0401641A3 (en) | Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors | |
| HK1073243A1 (en) | Use of N-(indolecarbonyl-) piperazine derivatives | |
| HK1053059A1 (zh) | 新用途 | |
| GB0109287D0 (en) | Therapeutic benzamide derivatives | |
| HUP0203929D0 (en) | New use of substituted alkyl-piridazinone derivatives | |
| ZA200305198B (en) | Substituted amine derivatives and methods of use. | |
| GB0109520D0 (en) | Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as njk-inhibitors | |
| AU2002237189A1 (en) | New use of phencynonate hydrochloride | |
| AU2002238356A1 (en) | New use of phencynonate hydrochloride | |
| SI1446399T1 (en) | Piperazine derivatives having sst1 antagonistic activity | |
| PL368985A1 (en) | Aryloxyphenyl and arylsulfanylphenyl derivatives | |
| SI1198453T1 (en) | N-(indolcarbonyl-)piperazin derivatives | |
| AU2002331263A1 (en) | N-((1-dimethylaminocycloalkyl)methyl)benzamide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20111028 |